Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease

Background The U.S. Preventive Services Task Force in 2009 recommended increased aspirin use for primary prevention of cardiovascular disease (CVD) in men ages 45 to 79 years and women ages 55 to 79 years for whom benefit outweighs risk. This study estimated the clinical efficacy and cost‐effectiven...

Full description

Bibliographic Details
Main Authors: Tzeyu L. Michaud, Jean Abraham, Hawre Jalal, Russell V. Luepker, Sue Duval, Alan T. Hirsch
Format: Article
Language:English
Published: Wiley 2015-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
aspirin
cardiovascular diseases
cost–effectiveness analysis
epidemiology
myocardial infarction
prevention
Online Access:https://doi.org/10.1161/JAHA.115.002321

Internet

https://doi.org/10.1161/JAHA.115.002321

Similar Items